New COVID-19 Related Genes – Helpful and Harmful – Found in Massive Screen
Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus.
The Pathoanatomy of Posterolateral Corner Ligamentous Disruption in Multiligament Knee Injuries Is Predictive of Peroneal Nerve Injury
A team of Yale researchers closely analyzed where the specific zone of ligamentous injury occurred in a consecutive group of patients who sustained a highly uncommon knee injury where more than one major knee ligament is damaged.
New Insights on Genetic Risks for Cigarette Smoking
Scientists have long understood that genes play an important role in a person’s smoking behavior, and a new genome-wide association study by Yale and U.S. Department of Veterans Affairs (VA) researchers is helping to explain why some people start to smoke, while others are able to quit.
WHRY Launches Studies on Endometrial Cancer, Addiction to Opioids, and Stroke
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
I'm Working on a COVID-19 Vaccine
From April, I led clinical trials on Remdesivir, a therapeutic drug that was granted emergency approval by the Food and Drug Administration (FDA) for treatment of COVID-19, and since August 26 I have been running trials of a vaccine for COVID-19 prevention at Yale New Haven Hospital.Source: Newsweek
Drugging the Undruggable: Yale Finds Treatment Path for Muscular Dystrophy
Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered “undruggable.”Source: YaleNews
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).Source: YaleNews
Strong Link Found Between Abnormal Liver Tests and Poor COVID-19 Outcomes
Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. They also discovered that higher levels of liver enzymes — proteins released when the liver is damaged — were associated with poorer outcomes for these patients, including ICU admission, mechanical ventilation, and death.Source: YaleNews
A Call for More COVID-19 Vaccine Funding, and Praise for Yale's Achievements
On July 24, United States Senator Richard Blumenthal (D-CT) highlighted research conducted at Yale School of Medicine and urged his Senate colleagues to approve more federal funding for development and distribution of vaccines to halt the COVID-19 pandemic.